"Elevated fibroblast growth factor-23 and risk for cardiovascular disease or mortality in the general population: A meta-analysis" by Karl Krupp

Article

Elevated fibroblast growth factor-23 and risk for cardiovascular disease or mortality in the general population: A meta-analysis

International Journal of Cardiology (2017)

Karl Krupp, Public Health Research Institute
Emir Veledar, Baptist Hospital of Miami
Purnima Madhivanan, Florida International University

Link

Publication Date

January 5, 2017

DOI

10.1016/j.ijcard.2017.02.116

Citation Information

Karl Krupp, Emir Veledar and Purnima Madhivanan. "Elevated fibroblast growth factor-23 and risk for cardiovascular disease or mortality in the general population: A meta-analysis" International Journal of Cardiology Vol. 235 (2017) p. 194
Available at: http://works.bepress.com/purnima-madhivanan/30/